RNU2‑1 gene copy number variations do not affect serum levels of miR‑1246 as a biomarker for lung adenocarcinoma
Experimental and Therapeutic Medicine · 27.02.2026 · 31 (5) · 1-7
DOI: 10.3892/etm.2026.13115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 27.02.2026. Verfasst von Makiko Ueda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Faculty of Health Sciences, Kyorin University, Mitaka, Tokyo 181-8612, Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Circulating microRNA (miR)-1246, a fragment of U2 small nuclear RNA, represents a promising biomarker for certain cancers, including lung adenocarcinoma. The gene that encodes miR-1246, RNU2-1, is located on human chromosome 17q21.31 and is organized as a tandem array that exhibits copy number variations (CNVs). The range of copy numbers has been reported to be quite wide, ranging from 5 to 82 per haploid genome. The present study analyzed the correlation between RNU2-1 copy numbers and serum miR-1246 levels in healthy controls and patients with stage IV lung adenocarcinoma. Serum miR-1246 levels were quantified using reverse transcription-quantitative polymerase chain reaction (PCR), and RNU2-1 copy numbers per diploid genome were measured via digital PCR using blood-derived DNA. The median copy numbers were 50 and 49 in the control and lung adenocarcinoma groups, respectively, with no significant difference observed between the groups. In addition, no correlation between RNU2-1 copy number and serum miR-1246 level was identified in either group. These results suggest that CNVs of RNU2-1 do not affect serum levels of the lung adenocarcinoma biomarker miR-1246.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Technology, Faculty of Health Sciences, Kyorin University, Mitaka, Tokyo 181-8612, Japan.
- Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa 241-8515, Japan.
- Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, Kanagawa 241-8515, Japan.
Zitieren
APA
Ueda, M., Sato, S., Miyagi, Y., & Aiso, T. (2026). RNU2‑1 gene copy number variations do not affect serum levels of miR‑1246 as a biomarker for lung adenocarcinoma. Experimental and Therapeutic Medicine, 31(5), 1-7. https://doi.org/10.3892/etm.2026.13115
Vancouver
Ueda M, Sato S, Miyagi Y, Aiso T. RNU2‑1 gene copy number variations do not affect serum levels of miR‑1246 as a biomarker for lung adenocarcinoma. Experimental and Therapeutic Medicine. 2026;31(5):1-7. doi:10.3892/etm.2026.13115
BibTeX
@article{Ueda2026,
author = {Ueda, Makiko and Sato, Shinya and Miyagi, Yohei and Aiso, Toshiko},
title = {RNU2‑1 gene copy number variations do not affect serum levels of miR‑1246 as a biomarker for lung adenocarcinoma},
journal = {Experimental and Therapeutic Medicine},
year = {2026},
volume = {31},
number = {5},
pages = {1--7},
doi = {10.3892/etm.2026.13115}
}
EUVIMED